Renal Cancer

A Review of Neoadjuvant Therapy for Localized and Locally Advanced Renal Cell Carcinoma. January 28, 2025

Endovascular Downstaging: A New Method for Managing Renal Cell Carcinoma Tumor Thrombus Invading the Inferior Vena Cava Above the Hepatic Veins (Level III) or into the Heart (Level IV). January 28, 2025

A Call for a Neoadjuvant Kidney Cancer Consortium: Lessons Learned from Other Cancer Types. January 27, 2025

Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter cohort study. January 27, 2025

Immune-Based and Novel Therapies in Variant Histology Renal Cell Carcinomas. January 27, 2025

CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation. January 24, 2025

Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma. January 24, 2025

Construction and evaluation of a prognostic model for metabolism-related genes in kidney renal clear cell carcinoma using TCGA database. January 23, 2025

Final Analysis of Post-Marketing Surveillance for Avelumab + Axitinib in Patients With Renal Cell Carcinoma in Japan. January 23, 2025

Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations. January 22, 2025

Medullary Renal Cell Carcinoma: A Case Study. January 22, 2025

Unmet needs in the management of patients with bilateral synchronous renal masses: the rationale for clinical decision-making. January 22, 2025

Clinical Applications of Microbiome in Renal Cell Carcinoma. January 21, 2025

Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study. January 21, 2025

Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC). January 20, 2025

Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? January 20, 2025

Circulating immune biomarkers correlating with response in patients with metastatic renal cell carcinoma on immunotherapy. January 17, 2025

First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. January 17, 2025

Paediatric renal tumours: an update on challenges and recent developments. January 16, 2025

Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal. January 16, 2025

Page 1 of 459